703. Cellular Immunotherapies other than CAR-T Cells: Poster II

Small molecule regulated BCMA CAR expression switch enables precise control of trispecific BCMA CD20 CD79b targeting PSC NK cell function against B cell related disorders

Differentiation of human induced pluripotent stem cells expressing chimeric antigen receptors into distinct immune cells as an off the shelf strategy for tumor treatments

T cell receptors targeting mutant NPM1 for adoptive cell therapy in acute myeloid leukemia

A long term antigen spreading by novel cancer vaccine with hyaluronic acid nanogel accelerate the anti neoplastic efficacy of cytotoxicity of infused TCR T cells and altered neplastic microenvironment